

[ Mon, Aug 15th 2022
] - WOPRAI

[ Tue, Jul 12th 2022
] - WOPRAI

[ Tue, Mar 29th 2022
] - WOPRAI

[ Tue, Nov 16th 2021
] - WOPRAI

[ Mon, Nov 15th 2021
] - WOPRAI

[ Wed, Sep 22nd 2021
] - WOPRAI

[ Thu, Sep 09th 2021
] - WOPRAI

[ Tue, Aug 17th 2021
] - WOPRAI

[ Thu, Jul 08th 2021
] - WOPRAI

[ Tue, Jun 29th 2021
] - WOPRAI

[ Thu, Mar 04th 2021
] - WOPRAI

[ Mon, Jan 25th 2021
] - WOPRAI

[ Thu, Oct 08th 2020
] - WOPRAI

[ Wed, Sep 16th 2020
] - WOPRAI

[ Wed, Sep 02nd 2020
] - WOPRAI

[ Wed, Aug 19th 2020
] - WOPRAI

[ Wed, May 06th 2020
] - WOPRAI
[ Wed, May 06th 2020
] - WOPRAI

[ Mon, May 04th 2020
] - WOPRAI

[ Mon, Mar 23rd 2020
] - WOPRAI

[ Thu, Oct 31st 2019
] - WOPRAI

[ Fri, Feb 28th 2014
] - WOPRAI



[ Fri, Dec 07th 2012
] - WOPRAI

[ Mon, Jul 09th 2012
] - WOPRAI
Nathan Weinstein Maintained (VNRX) at Strong Buy with Decreased Target to $6 on, Aug 15th, 2022
Nathan Weinstein of Aegis Capital, Maintained "VolitionRx Limited" (VNRX) at Strong Buy with Decreased Target from $9 to $6 on, Aug 15th, 2022.
Nathan, nor any peers, have made any analyst calls on VNRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30